By Business/Source
Currency:USD
2026/Q1
Stock NameRevenueRatio
DARZALEX562M62.72%
Net product sales116M12.95%
Kesimpta116M12.95%
Other38M4.24%
TEPEZZA26M2.90%
Milestone revenue16M1.79%
Collaboration revenue14M1.56%
Reimbursement revenue8M0.89%
View all
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
Denmark3.33B89.41%
Japan213M5.73%
United States180M4.84%
Netherlands1M0.03%